340 related articles for article (PubMed ID: 34685681)
1. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
3. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
Wang X; Li M; Hu Y
Physiol Res; 2023 Dec; 72(6):833-841. PubMed ID: 38215068
[TBL] [Abstract][Full Text] [Related]
4. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway.
Sha S; Shen X; Cao Y; Qu L
Aging (Albany NY); 2021 Jun; 13(11):15285-15306. PubMed ID: 34086603
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
9. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
He L; Chen Z; Wang J; Feng H
BMC Neurol; 2022 Jun; 22(1):203. PubMed ID: 35659599
[TBL] [Abstract][Full Text] [Related]
10. miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion.
Zhang X; Huang X; Fang C; Li Q; Cui J; Sun J; Li L
Mol Neurobiol; 2017 May; 54(4):2498-2506. PubMed ID: 26984601
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
Long JM; Ray B; Lahiri DK
J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
[TBL] [Abstract][Full Text] [Related]
12. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
Kumar S; Reddy AP; Yin X; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
[TBL] [Abstract][Full Text] [Related]
13. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
[TBL] [Abstract][Full Text] [Related]
15. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
[TBL] [Abstract][Full Text] [Related]
16. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
Ji Y; Wang D; Zhang B; Lu H
J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
[TBL] [Abstract][Full Text] [Related]
17. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
18. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
Wang WX; Rajeev BW; Stromberg AJ; Ren N; Tang G; Huang Q; Rigoutsos I; Nelson PT
J Neurosci; 2008 Jan; 28(5):1213-23. PubMed ID: 18234899
[TBL] [Abstract][Full Text] [Related]
19. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
[TBL] [Abstract][Full Text] [Related]
20. MRTF-A-mediated protection against amyloid-β-induced neuronal injury correlates with restoring autophagy via miR-1273g-3p/mTOR axis in Alzheimer models.
Zhang W; Yang Y; Xiang Z; Cheng J; Yu Z; Wang W; Hu L; Ma F; Deng Y; Jin Z; Hu X
Aging (Albany NY); 2022 May; 14(10):4305-4325. PubMed ID: 35604830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
